Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AI-Enhanced Risk Stratification for Targeted Chalazion Management: A Prospective Study on the Efficacy of Triamcinolone Acetonide and Intense Pulsed Light Therapy

  • By

  • Yanlin Zhong

  • Yiming Hu

  • Yuan Lin

  • Huping Wu

  • June 15, 2026

Share

Objective:

To evaluate the rates of chalazion recurrence following intralesional triamcinolone acetonide (TA), intense pulsed light (IPL), or combined TA + IPL therapy and to validate an AI-enhanced risk stratification strategy.

Key Findings:
  • Remove unsupported claims about combined TA + IPL therapy being particularly effective for high-risk patients.
Interpretation:

Remove this section as it contains unsupported conclusions.

Limitations:
  • Add any limitations mentioned in the source material.
Conclusion:

Revise to remove unsupported claims about the decision-support tool.

Original Source(s)

Related Content